L1CAM and intrahepatic cholangiocarcinoma: In addition, increased expression of L1CAM enhances proliferation, migration, invasion, and/or cisplatin resistance of ICC and GBC cells and tumor growth in vivo, while down-regulation of L1CAM reduces them [21, 24, 25].